The capsules are powered by V-Fill TM to ensure maximum absorption and bio-availability
Additional information Sources & References CURR PHARM DES BPC-157 & Angiogenic Growth Factors Tissue Healing 2018 Seiwerth S, Rucman R, Turkovic B, et al
Multiple focal pigmented lesions in the maxillary tuberosity and hard palate: a unique display of intraoral junctional nevi.Journal of Periodontology
Standard GHK-CU dosing protocols Most protocols recommend 1 to 2 milligrams daily
(2) Hillary H Le, Suleyman S Cinaroglu, Elise C Manalo, Aysegul Ors, et al (2021) Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine, 2021 Oct 21, Volume 73, Page 103646
The Pickart group has published gene-expression work in cultured fibroblasts reporting changes across several hundred genes after GHK-Cu exposure, with enrichment in tissue-remodeling and DNA-repair pathways (F